FIH trials are a critical milestone in clinical development, demanding precision, safety, and strategic foresight.
In our recent webinar, Ergomed experts shared their experience in designing and executing successful early-phase studies, from risk management to protocol flexibility and enhanced medical oversight. Download our summary guide to explore practical recommendations and expert-driven strategies to optimise your FIH programs.
